Mike Evers, Author at ORTHOWORLD

SI-BONE Increased FY23 Guidance After Fast Start

SI-BONE reported 1Q23 orthopedic sales of $32.7 million, +45.8% compared to the first quarter of 2021. A stabilizing macro environment,...

May 03, 2023

The company grew in the low double-digits due to improving procedure volumes and continued sales force execution.

May 02, 2023

The company's orthopedics business grew in the low-single digits for 1Q23 due to improved procedure volumes and execution.

May 01, 2023

The company grew 22% in 1Q23 due to improving surgical volumes and working through its warehouse-driven backlog from late-2022.

Apr 28, 2023

We tracked 32 orthopedic funding announcements in 2022, a modest slowdown after the flurry of investor activity in the wake of the pandemic.

Apr 24, 2023

Excluding the impact of currency translation, the company grew in the mid-single digits for the first quarter of 2023.

Apr 20, 2023

According to our estimates, the global orthopedic market exceeded $55 billion in sales in 2022, driven by procedure volume improvement.

Mar 31, 2023

We spoke to Enovis CEO Matt Trerotola about foundational implant technologies, ASC penetration, tech adoption and successful M&A deals.

Mar 21, 2023

The company's orthopedic sales grew in the high single digits for 2022, and it launched new cornerstone products in high-growth segments.

Mar 14, 2023

With the exception of the pandemic-ridden 2020, OrthoPediatrics has grown in excess of 20% every year since its founding.

Mar 13, 2023